http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7368912-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_48d6c04bbd72868ccce95468e832f2de
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-24
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-583
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-58
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01V3-00
filingDate 2006-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2008-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd220951c9e3928ca75fb45ce20e57b8
publicationDate 2008-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-7368912-B2
titleOfInvention Configuration for nuclear magnetic resonance imaging (MRI) with an MRI phantom
abstract An MRI configuration comprising an MRI phantom positioned in a volume under investigation, wherein the MRI phantom has a chamber disposed in a housing and filled with a liquid, in which a gas bubble forms, the liquid nuclei which have an NMR relaxation time T 1 of between 100 ms and 20 s, is characterized in that the chamber the MRI phantom a main chamber and a partial chamber, the main chamber being delimited from the partial chamber such that the gas bubble can completely enter the partial chamber due to its buoyancy by changing the spatial orientation of the MRI phantom in the gravitation field, and remains in the partial chamber in a measurement orientation of the MRI phantom due to its buoyancy. This eliminates imaging artefacts despite the presence of a gas bubble.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8814572-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10578702-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010013482-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10172587-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10620283-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009309593-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8072217-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008269594-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7768261-B2
priorityDate 2005-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002150539-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2209401-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7078015-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6605942-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 30.